← Leaderboards
Peter Jeffrey Rix
Quivive Pharma, Inc
$952,281
Attributed
$1,904,562
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2022–23$2M$1.5M$1M$500K$0
'22
'23
Funding mix
By agency
NIH$1,904,562 · 1
By mechanism
R44$1,904,562 · 1
Top collaborators
- Daniel I Sessler2 shared
Others in their field
Other Rising Stars on “Drug Combinations”
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Michael George Natchus · Emory University$10,548,554
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Robert C Alexander · Banner Health$5,015,602
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
Research focus
Drug CombinationsAdverse Event MonitoringAmericanAnalogBarbituratesBenzodiazepinesBlood GasAnalgesicsBuprenorphineBusinessesCanis FamiliarisCarbon DioxideChemistryChronicClinicClinical ResearchCollaborationsBody TemperatureDepressive SymptomsDesignDiastolic Blood PressureDoseDoxapramDrug Kinetics